FDA — Blog — Children's Cancer Cause

Posts tagged FDA

FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk

ResearchJessica KeanOctober 10, 2023neuroblastoma, FDA, ODAC, DFMO, relapse, remission

A New FDA-Approved Patient-Focused Drug Development Meeting on Reducing Cardiac Late Effects

ProgramsJessica KeanMarch 3, 2022PFDD, cardiac late effects, FDA

Call For More FDA Resources Included in New House Appropriations Bill

Call For More FDA Resources Included in New House Appropriations Bill

PolicySteve WosahlaJuly 12, 2021childhood cancer funding, Children's Cancer Cause, FDA, Pediatric Cluster, pediatric drug development, children's cancer drug development

FDA Approves Crizotinib for Treatment of Rare Lymphoma in Children

ResearchJessica KeanJanuary 15, 2021FDA, drug development, XALKORI, lymphoma

The RACE for Children Act Now in Full Effect

PolicyJessica KeanAugust 18, 2020RACE Act, FDA, drug development

Taking Action to Reduce Drug Shortages

PolicyJessica KeanDecember 11, 2019drug shortages, MEDS Act, vincristine, FDA